Literature DB >> 14592657

Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe.

Jiro Okami1, Keizo Dono, Masato Sakon, Masanori Tsujie, Nobuyasu Hayashi, Yoshiyuki Fujiwara, Hiroaki Nagano, Koji Umeshita, Shoji Nakamori, Morito Monden.   

Abstract

Lymph node involvement is an important prognostic factor in intrahepatic cholangiocarcinoma. Besides the nodes in the hepatoduodenal ligament, recent studies have suggested that the nodes around the cardiac portion of the stomach or along the gastric lesser curvature can be affected when the primary tumor is located in the left hepatic lobe. However, the distribution of metastatic nodes has not been well described in this disease. Thirteen patients with intrahepatic cholangiocarcinoma in the left hepatic lobe were enrolled in this study. Lymphatic mapping was performed by means of both histologic examination and reverse transcriptase-polymerase chain reaction assays. Nodal involvement around the cardiac portion of the stomach or along the lesser gastric curvature (left pathway) was found in 7 (54%) of 13 patients by histologic examination or reverse transcriptase-polymerase chain reaction, whereas positive nodes in the hepatoduodenal ligament (right pathway) were found in 6 (46%) of 13 patients. Two patients (15%) had positive nodes only in the left pathway. Therefore, for a more accurate clinical staging of intrahepatic cholangiocarcinoma in the hepatic left lobe, lymph nodes around the cardiac portion of the stomach and along the lesser gastric curvature should be examined in addition to nodes in the hepatoduodenal ligament.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592657     DOI: 10.1007/s11605-003-0029-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  14 in total

Review 1.  Biliary tract cancers.

Authors:  P C de Groen; G J Gores; N F LaRusso; L L Gunderson; D M Nagorney
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

Review 2.  Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities.

Authors:  Ken Shirabe; Mitsuo Shimada; Norifumi Harimoto; Keishi Sugimachi; Yo-ichi Yamashita; Eiji Tsujita; Shin-ichi Aishima
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

3.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

4.  Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.

Authors:  J Okami; K Dohno; M Sakon; K Iwao; T Yamada; H Yamamoto; Y Fujiwara; H Nagano; K Umeshita; N Matsuura; S Nakamori; M Monden
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

5.  Resection of intrahepatic cholangiocarcinoma: a Western experience.

Authors:  A Valverde; N Bonhomme; O Farges; A Sauvanet; J F Flejou; J Belghiti
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

6.  Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma.

Authors:  M Shimada; Y Yamashita; S Aishima; K Shirabe; K Takenaka; K Sugimachi
Journal:  Br J Surg       Date:  2001-11       Impact factor: 6.939

7.  Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma.

Authors:  T Isa; T Kusano; H Shimoji; Y Takeshima; Y Muto; M Furukawa
Journal:  Am J Surg       Date:  2001-06       Impact factor: 2.565

8.  Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management.

Authors:  Z E El Rassi; C Partensky; J Y Scoazec; L Henry; C Lombard-Bohas; G Maddern
Journal:  Eur J Surg Oncol       Date:  1999-08       Impact factor: 4.424

9.  Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma.

Authors:  Y Nozaki; M Yamamoto; I Ikai; Y Yamamoto; N Ozaki; H Fujii; K Nagahori; Y Matsumoto; Y Yamaoka
Journal:  Cancer       Date:  1998-11-01       Impact factor: 6.860

10.  Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression.

Authors:  S Chretien; A Dubart; D Beaupain; N Raich; B Grandchamp; J Rosa; M Goossens; P H Romeo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

View more
  10 in total

1.  Intrahepatic cholangiocarcinoma: expert consensus statement.

Authors:  Sharon M Weber; Dario Ribero; Eileen M O'Reilly; Norihiro Kokudo; Masaru Miyazaki; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

2.  Intrahepatic cholangiocarcinoma.

Authors:  Kimberly M Brown; Abhishek D Parmar; David A Geller
Journal:  Surg Oncol Clin N Am       Date:  2014-04       Impact factor: 3.495

Review 3.  Surgical treatment for intrahepatic cholangiocarcinoma.

Authors:  Takahiro Uenishi; Takatsugu Yamamoto; Shigekazu Takemura; Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2014-02-15

4.  Oncologic Impact of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a Propensity Score-Matched Study.

Authors:  Sung Hyun Kim; Dai Hoon Han; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2018-08-15       Impact factor: 3.452

5.  Long-term survival of a patient with common bile duct cancer after Virchow's node recurrence: Report of a case.

Authors:  Toshiya Ochiai; Hisashi Ikoma; Koji Inoue; Shuhei Komatsu; Yasutoshi Murayama; Atsushi Shiozaki; Yoshiaki Kuriu; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Yukihito Kokuba; Teruhisa Sonoyama; Eigo Otsuji
Journal:  Surg Today       Date:  2011-09-16       Impact factor: 2.549

6.  Solitary recurrence of hilar cholangiocarcinoma in a mediastinal lymph node two years after curative resection.

Authors:  Yuichiro Ito; Yoshitsugu Tajima; Fumihiko Fujita; Ryuji Tsutsumi; Tamotsu Kuroki; Takashi Kanematsu
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

7.  Staging cholangiocarcinoma by imaging studies.

Authors:  V Vilgrain
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 8.  Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings.

Authors:  Mohammed Saleh; Mayur Virarkar; Vlad Bura; Raul Valenzuela; Sanaz Javadi; Janio Szklaruk; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-11

9.  The Landmark Series: Intrahepatic Cholangiocarcinoma.

Authors:  Jordan M Cloyd; Aslam Ejaz; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2020-05-17       Impact factor: 5.344

Review 10.  Current status of intrahepatic cholangiocarcinoma.

Authors:  Jian Yang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.